Onkologische Erkrankungen im Alter

Mehr als die Hälfte der Menschen mit einer neu diagnostizierten onkologischen Erkrankung ist über 70 Jahre alt. In dieser Altersgruppe ist die Tumorbehandlung mit anderen Herausforderungen verbunden als bei Betroffenen im jüngeren Lebensalter. Dieser Beitrag fasst dazu den gegenwärtigen Erkenntnisstand zusammen und beschreibt die Besonderheiten von Diagnostik und Therapie onkologischer Erkrankungen im Alter.

Schlüsselwörter

Frailty - geriatrisches Assessment - Chemotherapie - Präzisionsmedizin

Keywords

frailty - geriatric assessment - chemotherapy - precision medicine

• Literatur

• 1 Robert-Koch-Institut, Zentrum für Krebsregisterdaten. Bericht zum Krebsgeschehen in Deutschland 2016. Im Internet (Stand: 19.05.2021): http://www.krebsdaten.de/Krebs/DE/Content/Publikationen
• 2 Aunan JR, Cho WC, Soreide K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis 2017; 8: 628-642
• 3 Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014; 69 (01) S4-S9
• 4 Hurria A, Dale W, Mooney M. et al. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 2014; 32: 2587-2594
• 5 Hamaker ME, Stauder R, van Munster BC. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist 2014; 19: 1069-1075
• 6 Clegg A, Young J, Iliffe S. et al. Frailty in elderly people. Lancet 2013; 381: 752-762
• 7 Jolly TA, Deal AM, Nyrop KA. et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist 2015; 20: 379-385
• 8 Bellera CA, Rainfray M, Mathoulin-Pelissier S. et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012; 23: 2166-2172
• 9 Wildiers H, Heeren P, Puts M. et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014; 32: 2595-2603
• 10 Hamaker ME, Te Molder M, Thielen N. et al. The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients – A systematic review. J Geriatr Oncol 2018; 9: 430-440
• 11 Rockwood K, Song X, MacKnight C. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489-495
• 12 Charlson ME, Pompei P, Ales KL. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
• 13 Hurria A, Togawa K, Mohile SG. et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29: 3457-3465
• 14 Extermann M, Boler I, Reich RR. et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012; 118: 3377-3386
• 15 Puts M, Soo WK, Szumacher E. et al. Methods for frailty screening and geriatric assessment in older adults with cancer. Curr Opin Support Palliat Care 2021; 15: 16-22
• 16 Lavoue V, Gotlieb W. Benefits of Minimal Access Surgery in Elderly Patients with Pelvic Cancer. Cancers (Basel) 2016; 8
• 17 Daniels SL, Lee MJ, George J. et al. Prehabilitation in elective abdominal cancer surgery in older patients: systematic review and meta-analysis. BJS Open 2020;
• 18 Desideri I, Salvestrini V, Livi L. Recent advances in de-intensification of radiotherapy in elderly cancer patients. F1000Res 2020; 9
• 19 Hall PS, Lord SR, Collinson M. et al. A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). Br J Cancer 2017; 116: 472-478
• 20 Wildiers H, de Glas NA. Anticancer drugs are not well tolerated in all older patients with cancer. The Lancet Healthy Longevity 2020; 1: e43-e47